Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma - ScienceDirect
MMupdate | Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA ...
Vantaggi dall'aggiunta di daratumumab a VTd nei pazienti con MM eleggibili al trapianto - Ematoinfo
EHA Library - The official digital education library of European Hematology Association (EHA)
Cureus | Efficacy of Daratumumab-Based Regimens Compared to Standard of Care in Transplant-Eligible Multiple Myeloma: A Meta-Analysis | Article
Treatment of new diagnosed myeloma patients - International Myeloma Society
CASSIOPEIA - Dara-VTd - Multiple Myeloma Clinical Trials
ROLE OF DARATUMUMAB IN NEWLY DIAGNOSED MULTIPLE MYELOMA.pptx
Ben Derman on X: "CASSIOPEIA MRD analysis: Take a look at the top two PFS curves for Dara-VTd vs. VTd among MRD-negative patients. Doesn't seem like sustained MRD-negativity behaves the same? For
Daratumumab maintenance after treatment with VTd w/DARA and ASCT in pts with NDMM: CASSIOPEIA Part 2 - YouTube
CASSIOPEIA Trial of Dara-VTd in Transplant-Eligible Myeloma
Vincent Rajkumar on X: "Philippe Moreau is rubbing it in! IFM accrued 1085 patient with Newly Diagnosed MM in to the Dara-VTD vs VTD trial in 2 years! Astounding! We cannot do
Frontiers | Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
A20-15 - Daratumumab - Extract of dossier assessment - Version 1.0
Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
Ben Derman on X: "CASSIOPEIA MRD analysis: Take a look at the top two PFS curves for Dara-VTd vs. VTd among MRD-negative patients. Doesn't seem like sustained MRD-negativity behaves the same? For
Daratumumab maintenance after treatment with VTd w/DARA and ASCT in pts with NDMM: CASSIOPEIA Part 2
PDF) Prognostic value of positron emission tomography/computed tomography in transplanteligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial | Haematologica
Cleveland Clinic Taussig Cancer Institute | VuMedi
Maintenance therapies in Multiple Myeloma - ppt download
